Crestline Management, LP Dynavax Technologies Corp Transaction History
Crestline Management, LP
- $63.2 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding DVAX
# of Institutions
311Shares Held
129MCall Options Held
493KPut Options Held
269K-
Black Rock Inc. New York, NY21.9MShares$225 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$183 Million8.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.7MShares$89.4 Million0.0% of portfolio
-
State Street Corp Boston, MA6.79MShares$69.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.75MShares$59.1 Million4.84% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.3B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...